Success story of Sun Pharma


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴
In 1983, Sun Pharma moved to Vapi, Gujarat and started with just 5 people and five products. Today the company has expanded into 24 countries with over $21 billion in revenues.

Dilip Shanghvi lived a normal life. His father had a pharmaceutical drugs trading business. In his younger years, Dilip started helping his father’s business. After completing his studies in Commerce from Calcutta University, he decided to start a business of his own. He took a mere Rs 10 thousand and went on to create Sun Pharma in the year 1982. Starting with just 1 employee, Dilip started selling psychiatry medicine in Kolkata. Instead of focusing on generic medicines which would require a field force, he stuck to psychiatry medicines as the number of physiatrists were fewer and could easily be targeted. 

Dilip then realised the worth of making their own products. In 1983, Sun Pharma moved to Vapi, Gujarat and started with just 5 people and five products. Since its inception, this venture has focused on making high-margin chronic care therapy products which have gained massive fortunes for Dilip and his company. Sun Pharma started selling pan-India in 1987. On the ORG Pharma list, the company ranked at 108 position. In 2007, they had climbed to the spot of 6 with a domestic market share of 3.2%. During the same period, they have earned Rs 21,271 crores. 

The company did its IPO in the year 1994 and two years later expanded its horizon in 24 countries. This included some tough and highly regulated markets like Europe and the USA. In 2011, Sun Pharma became the first Indian pharmaceutical company to earn $2 billion with one single product. Sun Pharma had earned that amount with its product Ranbaxy. In 2012, when Sun Pharma acquired URL Pharma Inc. and DUSA Pharmaceuticals Inc. Such acquisitions have cemented the success of Dilip Shanghvi who owns a 60.8% stake in the company with a net worth of over $21 billion.

Tags : #DilipShanghvi #SunPharma #success #pharmaceutical #successstory #smitakumar #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026